3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
21
Lung Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
8
Prostatic Neoplasms
8
Stomach Neoplasms
4
Prostatic Neoplasms, Castration-Resistant
4
Breast Neoplasms
4
Neoplasms
3
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Melanoma
2
Lymphoid Interstitial Pneumonia
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Carcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Tongue Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
1
Interventions
Rituximab
12
Biopsy
12
Specimen Handling
11
Cyclophosphamide
11
Magnetic Resonance Spectroscopy
10
obinutuzumab
7
Lenalidomide
7
fludarabine
6
Prednisone
6
pembrolizumab
5
Nuclear Medicine Department, Hospital
5
X-Rays
4
Doxorubicin
4
venetoclax
3
ibrutinib
3
glofitamab
3
fludarabine phosphate
3
acalabrutinib
3
Vincristine
3
Tacrolimus
3
Mycophenolic Acid
3
GSK2636771
3
Etoposide
3
Busulfan
3
Bendamustine Hydrochloride
3
zanubrutinib
2
trametinib
2
tocilizumab
2
palbociclib
2
osimertinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Docetaxel
×
30 days
×
Clear all
No trials found.